Anti-adhesion molecule therapy in Theiler's murine encephalomyelitis virus-induced demyelinating disease

International Immunology

Volumn 9, Issue 12, 1997, Pages 1837-1847

  Inoue, Atsushi ^a   Koh, Chang Sung ^a   Yamazaki, Masashi ^a   Ichikawa, Motoki ^a   Isobe, Mitsuaki ^a   Ishihara, Yoshihiro ^b   Yagita, Hideo ^c   Kim, Byung S ^d  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Machida Sakuranbo Hospital   (Japan)

^c JUNTENDO UNIVERSITY   (Japan)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Adhesion molecule; Demyelination; ICAM 1; LFA 1; Multiple sclerosis; Theiler's murine encephalomyelitis virus

Indexed keywords

GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 4; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DELAYED HYPERSENSITIVITY; DEMYELINATING DISEASE; ENDOTHELIUM CELL; FEMALE; IMMUNOHISTOCHEMISTRY; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; SPLEEN CELL; VIRUS PATHOGENESIS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; CYTOKINES; DEMYELINATING DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HYPERSENSITIVITY, DELAYED; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MICE; MICE, INBRED STRAINS; POLIOMYELITIS; T-LYMPHOCYTES; THEILOVIRUS;

EID: 0031455406     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/9.12.1837     Document Type: Article

References (58)

1. Hauser, S. L. 1994. Multiple sclerosis and other demyelinating diseases. In Isselbacher, K. J., ed., Harrison's Principles of Internal Medicine, 13 edn, p. 2287. McGraw-Hill, New York.
2. Aubert, C., Chamorro, M. and Brahic, M. 1987. Identification of Theiler's virus infected cells in the central nervous system of the mouse during demyelinating disease. Microb. Pathog. 3:319.
3. Brahic, M., Stroop, W. G. and Baringer, J. R. 1981. Theiler's virus persists in glial cells during demyelinating disease. Cell 26:123.
4. Lipton, H. L., Kratochvil, J., Sethi, P. and Dal Canto, M. C. 1984. Theiler's virus antigen detected in mouse spinal cord 2 1/2 years after infection. Neurology 34:1117.
5. Rodriguez, M., Pease, L. R. and David, C. S. 1986. Immune mediated injury of virus-infected oligodendrocytes. Immunol. Today 7:359.
6. + T cell-mediated pathology. J. Immunol. 156:4050.
7. Calder, V., Owen, S., Watson, C., Feldmann, M. and Davison, A. 1989. MS: a localized immune disease of the central nervous system. Immunol. Today 10:99.
8. Melvold, R. W., Jokinen, D. M., Miller, S. D., Dal Canto, M. C. and Lipton, H. L. 1990. Identification of a locus on mouse chromosome 3 involved in differential susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Virol. 64:686.
9. Clatch, R. J., Melvold, R. W., Miller, S. D. and Lipton, H. L. 1985. Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TMEV-specific delayed-type hypersensitivity. J. Immunol. 135:1408.
10. Rodriguez, M., and David, C. S. 1985. Demyelination induced by Theiler's virus: influence of the H-2 haplotype. J. Immunol. 135:2145.
11. Rodriguez, M., Leibowitz, J. and David, C. S. 1986. Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region. J. Exp. Med. 163:620.
12. Kappel, C. A., Dal Canto, M. C., Melvold R. W. and Kim, B. S. 1991. Hierarchy of effects of the MHC and T cell receptor β-chain genes in susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Immunol. 147:4322.
13. Melvold, R. W., Jokinen, D. M., Knobler, R. L. and Lipton, H. L. 1987. Variations in genetic control of susceptibility to Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Differences between susceptible SJL/J and resistant BALB/c strains map near the T cell beta-chain constant gene on chromosome 6. J. Immunol. 138:1429.
14. β deletion. J. Virol. 71:4181.
15. Lipton, H. L. and Dal Canto, M. C. 1976. Theiler's virus-induced demyelination: prevention by immunosuppression. Science 192:62.
16. Roos, R. P., Firestone, S., Wollmann, R., Variakojis, D. and Arnason, B. G. 1982. The effect of short-term and chronic immunosuppression on Theiler's virus demyelination. J. Neuroimmunol. 2:223.
17. Inoue, A., Koh, C.-S., Yanagisawa, N., Taketomi, T. and Ishihara, Y. 1996. Suppression of Theiler's murine encephalomyelitis virus induced demyelinating disease by administration of gangliosides. J. Neuroimmunol. 64:45.
18. Rodriguez, M., Lafuse, W. P., Leibowitz, J. and David, C. S. 1986. Partial suppression of Theiler's virus-induced demyelination in vivo by administration of monoclonal antibodies to immune-response gene products (la antigens). Neurology 36:964.
19. Welsh, C., Tonks, P., Nash, A. A. and Blakemore, W. F. 1987. The effect of L3T4T cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice J. Gen. Virol. 68:1659.
20. + T cell line specific for an immunodominant VP2 epitope. J. Immunol. 152:919.
21. Rodriguez, M. and Sriam, S. 1988. Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt2 antibody. J. Immunol. 140:2950.
22. Inoue, A., Koh, C.-S., Yahikozawa, H., Yanagisawa, N., Yagita. H., Ishihara, Y. and Kim B. S. 1996. The level of tumor necrosis factor-α producing cells in the spinal cord correlates with the degree of Theiler's murine encephalomyelitis virus-induced demyel-nating disease. Int. Immunol. 8:1001.
23. Dustin, M. L. and Springer, T. A. 1989. T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 341:619.
24. Harding, C. V. and Unanue, E. R. 1991. Modulation of antigen presentation and peptide-MHC-specific, LFA-1-dependent T cell-macrophage adhesion. J. Immunol. 147:767.
25. Oppenheimer, M. N., Davis, L. S., Bogue, D. T., Ramberg, J. and Lipsky, P. E. 1991. Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes. J. Immunol. 147:2913.
26. Unanue, E. R. 1993. Macrophages, antigen-presenting cells, and the phenomena of antigen handling and presentation In Paul, W. E., ed., Fundamental Immunology, 3rd edn, p. 111. Raven Press, New York.
27. Hauser, S. L., Bhan, A. K. and Gilles, F. 1986. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann. Neurol. 19:578.
28. Lindsley, M. D. and Rodriguez, M. 1989. Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus. J Immunol. 142:2677.
29. Wekerle, H., Linington, C., Lassman, H. and Myermann, R. 1986. Cellular immune reactivity within the CNS. Trends Neurosci. 9:271.
30. Hickey, W. F., Hsu, B. L. and Kimura, H. 1991. T-lymphocyte entry in the central nervous system. J Neurosci. Res. 28:254.
31. Wong, D. and Dorovini-Zis, K. 1992. Upregulation of intercellular adhesion molecule-1 (ICAM-1) expression in primary cultures of human brain microvessel endothelial cells by cytokines and lipopolysaccharide. J. Neuroimmunol. 39:11.
32. Fabry, Z., Waldschmidt, M., Hendrickson, D., Keiner, J., Love-Homan. L., Takei, F. and Hart, M. 1992. Adhesion molecules on murine brain microvasculature endothelial cells: expression and regulation of ICAM-1 and Lgp 55. J. Neuroimmunol. 36:1.
33. Male, D., Pryce, G., Hughes, C. and Lantos, P. 1990. Lymphocyte migration into brain modeled in vitro: control by lymphocyte activation, cytokines, and antigen. Cell. Immunol. 30:161.
34. Willcox, C., Ward, A., Evans, A., Baker, D., Rothlein, R. and Turk, J 1990. Endothelial cell expression of the intercellular adhesion molecule-1 (ICAM-1) in the central nervous system of guinea pigs during acute and chronic relapsing experimental allergic encephalomyelitis. J. Neuroimmunol. 30:43.
35. Cannella, B., Cross, A. and Raine, C. 1991. Adhesion molecules in the central nervous system. Upregulation correlates with inflammatory cell influx during relapsing experimental autoimmune encephalomyelitis. Lab. Invest. 65:23.
36. Dopp, J. M., Breneman, S. M. and Olschowka, J. A. 1994. Expression of ICAM-1, VCAM-1, L-selectin and leukosialin in the mouse central nervous system during the induction and remission stages of experimental allergic encephalomyelitis. J Neuroimmunol. 54:129.
37. Archelos, J. J., Jung, S., Mäurer, M., Schmied, M., Lassmann, H., Tamatani, T., Miyasaka, M., Toyka, K. V. and Hartung, H.-P. 1993. Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intracellular adhesion molecule ICAM-1, Ann. Neurol. 34:145.
38. Kawai, K., Kobayashi, Y., Shiratori, M., Sobue, G., Tamatani, T., Miyasaka, M. and Yoshikai, Y. 1966. Intrathecal administration of antibodies against LFA-1 and ICAM-1 suppresses experimental allergic encephalomyelitis in rats. Cell. Immunol. 171:262.
39. Lipton, H. L. and Friedmann, A. 1980. Purification of Theiler's murine encephalomyelitis virus and analysis of the structural virion polypeptides: Correlation of the polypeptide profile with virulence. J. Virol. 33:1165.
40. Nishimura, T., Yagi, H., Yagita, H., Uchiyama, Y. and Hashimoto, Y. 1985. Lymphokine-activated cell associated antigen involved in broad reactive killer cell-mediated cytotoxicity. Cell. Immunol. 94:122.
41. Sanchez-Madrid, F., Simon, P., Thompson, S. and Springer, T. A. 1983. Mapping of antigen and functional epitopes on the a- and b-subunits of two related mouse glycoproteins involved in cell interactions, LFA-1 and MAC-1, J. Exp. Med. 158:586.
42. Takei, F. 1986. Inhibition of mixed lymphocyte response by a rat mAb to a novel murine lymphocyte activation antigen (MALA-2). J. Immunol. 134:1403.
43. Prieto, J., Takei, F., Gendelman, R., Christenson, B., Biberfeld, P. and Patarroyo, M., 1989. MALA-2, mouse homologue of human adhesion molecule ICAM-1 (CD54). Eur. J. Immunol. 19:1551.
44. Crane, M. A., Jue, C., Mitchell, M., Lipton, H. L. and Kim, B. S. 1990. Detection of restricted predominant epitopes of Theiler's murine encephalomyelitis virus capsid proteins expressed in the Igt11 system: different patterns of antibody reactivity among different mouse strains. J. Neuroimmunol. 27:173.
45. Karpus, W. J., Pope, J. G., Peterson, J. D., Dal Canto, M. C. and Miller, S. D. 1995. Inhibition of Theiler's virus-mediated demyelination by peripheral immune tolerance induction. J. Immunol. 155:947.
46. Lipton, H. L. 1975 Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect. Immun. 11:1147.
47. Cannella, B., Cross, A. and Raine, C. 1993. Anti-adhesion molecule therapy in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 46:43.
48. Inoue, A., Choe, Y.-K. and Kim, B. S. 1994. Analysis of antibody response to predominant linear epitopes of Theiler's murine encephalomyelitis virus. J. Virol. 68:3324.
49. Czerinsky, C., Tarkowski, A., Nilsson, L.-A., Ouchterlony, O., Nygren, H. and Gretzer, C. 1984. Reverse enzyme-linked immunospot (RELISPOT) assay for detection of cells secreting immunoreactive substances. J. Immunol. Methods 72:489.
50. Li, L., Elliot, J. F. and Mosmann, T. R. 1994. IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed type hypersensitivity. J. Immunol. 153:3967.
51. Pullen, L. C., Miller, S. D., Dal Canto, M. C. and Kim, B. S. 1993. Class I-deficient resistance mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination. Eur. J. Immunol. 23:2287.
52. Miller, S. D., Clatch, R. J., Pevear, D. C., Trotter, J. L. and Lipton, H. L. 1987. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Cross-specificity among TMEV substrains and related picornaviruses, but not myelin proteins. J. Immunol. 138:3776.
53. Springer, T. A. 1990. Adhesion receptors of the immune system. Nature 346:425.
54. Isobe, M., Yagita, H., Okumura, K. and Ihara, A. 1992 Specific acceptance of cardiac allograft after treatment with anti-ICAM-1 and anti-LFA-1. Science 255:1125.
55. Hasegawa, Y., Yokono, K., Taki, T., Amano, K., Tominaga, Y., Yoneda, R., Yagi, N., Maeda, S., Yagita, H., Okumura, K. and Kasuga, M. 1994. Prevention of autoimmune insulin-dependent diabetes in non-obese diabetic mice by anti-LFA-1 and anti-ICAM-1 mAb. Int. Immunol. 6:831.
56. Welsh, C. T., Rose, J. W., Hill, K. E. and Townsend, J. J. 1993. Augmentation of adoptively transferred experimental allergic encephalomyelitis by administration of a monoclonal antibody specific for LFA-1α. J. Neuroimmunol. 43:161.
57. Gordon, E. J., Myers, K. J., Dougherty J. P., Rosen, H. and Ron, Y. 1995. Both anti-CD11a (LFA-1) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 62:153.
58. Faory, Z., Raine, C. S. and Hart, M. N. 1994. Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol. Today 15:218.